Arnaud, Laurent <br/><br/>
Drug-induced systemic lupus: revisiting the ever-changing spectrum of the disease using the WHO pharmacovigilance database.  [electronic resource] 

 -  Annals of the rheumatic diseases  04 2019 
 - 504-508 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1468-2060 
<br/><br/><label>Standard No.: </label>10.1136/annrheumdis-2018-214598  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab--adverse effects<br/>Adult<br/>Antirheumatic Agents--adverse effects<br/>Databases, Factual<br/>Etanercept--adverse effects<br/>Female<br/>Humans<br/>Hydralazine--adverse effects<br/>Infliximab--adverse effects<br/>Lupus Erythematosus, Systemic--chemically induced<br/>Male<br/>Middle Aged<br/>Pharmacovigilance<br/>Procainamide--adverse effects<br/>Retrospective Studies<br/>World Health Organization